STATIN THERAPY IN A PRIMARY PREVENTION PATIENT WITH SEVERE HYPERCHOLESTEROLEMIA AND ELEVATED LIVER ENZYME LEVELS

Despite the cardiovascular benefit of statin therapy in primary and secondary prevention, introduction of statin may be challenging when baseline serum liver enzymes (LE) are elevated. A primary prevention 62 y-old obese woman with high LDL-C, hypertension and diabetes, presented with LE > 3x upper